Cardioprotective effects of nitroparacetamol and paracetamol in myocardial infarction
C CHONG,Y ZHU,P MOORE
DOI: https://doi.org/10.1016/j.annemergmed.2004.07.169
IF: 6.762
2004-01-01
Annals of Emergency Medicine
Abstract:Study objectives: The biology of nitric oxide has been extensively studied for many years. Currently, researchers are investigating the possibility that slow-release nitric oxide donors (nitric oxide–donating drugs) may produce biological effects quite different from classic nitric oxide donors (eg, sodium nitroprusside). The precise role of nitric oxide in many cardiovascular diseases remains unclear. In our current study, we aim to determine whether nitroparacetamol (nitric oxide donor) exhibits cardioprotective effects. Methods: Male Wistar rats weighing between 220 and 250 g were used. Treatment groups included vehicle, nitroparacetamol, paracetamol, and ramipril. These drugs were given by the intraperitoneal route at doses of 5 mL/kg/day, 5 mg/kg/day, 15 mg/kg/day, and 0.5 mg/kg/day, respectively. Drug treatment was started 1 week before surgery. Myocardial infarction was induced by permanent ligation of the left anterior descending coronary artery and mortality rate at 2 days after myocardial infarction induction was compared. Infarction size was also compared between these groups. Results: Mortality rates for vehicle (n=60), nitroparacetamol (n=60), paracetamol (n=60), and ramipril (n=60) groups were 38%, 25%, 20%, and 28% respectively. A corresponding reduction in infarction size in the groups with better survival rate was noted. Infarction size for the vehicle group was 48% (±6%) of the left ventricle and for the ramipril group was 38% (±3%). For the nitroparacetamol and paracetamol groups, infarction size was 30% (±8%) and 32% (±6%) of the left ventricle, respectively. These were statistically significant when compared with the vehicle group. Nitroparacetamol and paracetamol administration in this way did not have any discernible effects on blood pressure in these animals. Conclusion: The study is underpowered to show statistical significance of the difference in mortality rate obtained. Nevertheless, the observation that paracetamol and nitroparacetamol produce a lower mortality rate than ramipril, an angiotensin-converting enzyme inhibitor, indicates the potential clinical significance of the cardioprotective effects of these drugs. The significant reduction in infarction size further reinforces this conclusion. Study objectives: The biology of nitric oxide has been extensively studied for many years. Currently, researchers are investigating the possibility that slow-release nitric oxide donors (nitric oxide–donating drugs) may produce biological effects quite different from classic nitric oxide donors (eg, sodium nitroprusside). The precise role of nitric oxide in many cardiovascular diseases remains unclear. In our current study, we aim to determine whether nitroparacetamol (nitric oxide donor) exhibits cardioprotective effects. Methods: Male Wistar rats weighing between 220 and 250 g were used. Treatment groups included vehicle, nitroparacetamol, paracetamol, and ramipril. These drugs were given by the intraperitoneal route at doses of 5 mL/kg/day, 5 mg/kg/day, 15 mg/kg/day, and 0.5 mg/kg/day, respectively. Drug treatment was started 1 week before surgery. Myocardial infarction was induced by permanent ligation of the left anterior descending coronary artery and mortality rate at 2 days after myocardial infarction induction was compared. Infarction size was also compared between these groups. Results: Mortality rates for vehicle (n=60), nitroparacetamol (n=60), paracetamol (n=60), and ramipril (n=60) groups were 38%, 25%, 20%, and 28% respectively. A corresponding reduction in infarction size in the groups with better survival rate was noted. Infarction size for the vehicle group was 48% (±6%) of the left ventricle and for the ramipril group was 38% (±3%). For the nitroparacetamol and paracetamol groups, infarction size was 30% (±8%) and 32% (±6%) of the left ventricle, respectively. These were statistically significant when compared with the vehicle group. Nitroparacetamol and paracetamol administration in this way did not have any discernible effects on blood pressure in these animals. Conclusion: The study is underpowered to show statistical significance of the difference in mortality rate obtained. Nevertheless, the observation that paracetamol and nitroparacetamol produce a lower mortality rate than ramipril, an angiotensin-converting enzyme inhibitor, indicates the potential clinical significance of the cardioprotective effects of these drugs. The significant reduction in infarction size further reinforces this conclusion.